Susquehanna International Group, LLP Vaccinex, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$0.44 - $131.17 $12,452 - $3.71 Million	28,300 New	28,300 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.04 - $2.12 $12,688 - $25,864	-12,200 Reduced 11.01%	98,600 $103,000
Q3 2021 Nov 15, 2021	BUY	$2.11 - $2.81 $203,615 - $271,165	96,500 Added 674.83%	110,800 $239,000
Q2 2021 Aug 11, 2021	SELL	$2.01 - $3.0 $20,702 - $30,900	-10,300 Reduced 41.87%	14,300 $40,000
Q1 2021 May 17, 2021	SELL	$2.09 - $5.11 $61,236 - $149,723	-29,300 Reduced 54.36%	24,600 $73,000
Q4 2020 Feb 16, 2021	BUY	$1.66 - $2.35 $69,056 - $97,760	41,600 Added 338.21%	53,900 $112,000
Q3 2020 Nov 16, 2020	BUY	$1.75 - $8.19 $21,525 - $100,737	12,300 New	12,300 $22,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $240M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.